精选安全与合规美国 FDAT1084
Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
🤖 AI 摘要
The FDA issued a LHCP to notify providers that Stereotactic Breast Biopsy Needles (product code KNW) are experiencing a supply disruption.
分析模型：rule-based-v3 · 07-09 06:59
评分详情
综合分 84/100
信源权威
95
影响范围
75
时效性
50
合规紧急
90
行业关注
90
MedWatch Safety Alerts (医疗产品安全警报)
操作：